A Novel DNA Variant in SMARCA4 Gene Found in a Patient Affected by Early Onset Colon Cancer
Authors:
Open Access
- 27 February 2024
- journal article
- case report
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (5) , 2716
Abstract
Colorectal cancer is the third leading cause of death from neoplasia worldwide. Thanks to new screening programs, we are now seeing an increase in Early Onset of ColoRectal Cancer (EOCRC) in patients below the age of 50. Herein, we report a clinical case of a woman affected by EOCRC. This case illustrates the importance of genetic predisposition testing also in tumor patients. Indeed, for our patient, we used a combined approach of multiple molecular and cellular biology technologies that revealed the presence of an interesting novel variant in the SMARCA4 gene. The latter gene is implicated in damage repair processes and related, if mutated, to the onset of various tumor types. In addition, we stabilized Patient-Derived Organoids from the tumor tissue of the same patient and the result confirmed the presence of this novel pathogenic variant that has never been found before even in early onset cancer. In conclusion, with this clinical case, we want to underscore the importance of including patients even those below the age of 50 years in appropriate screening programs which should also include genetic tests for predisposition to early onset cancers.Keywords
Funding Information
- Ministero della Salute (RF-2010-23183729, 366/2018, 2014/2020, 752/2019, 38/2020)
- Regione Campania (RF-2010-23183729, 366/2018, 2014/2020, 752/2019, 38/2020)
This publication has 47 references indexed in Scilit:
- Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancerCancer Medicine, 2023
- Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancerCell Reports, 2023
- Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset casesJournal of Gastroenterology, 2023
- The performance of multi-gene panels for breast/ovarian cancer predispositionClinica Chimica Acta, 2022
- Cell line models for drug discovery in PIK3CA-mutated colorectal cancersMedical Oncology, 2022
- Ovarian carcinoma in children with constitutional mutation of SMARCA4: single-family report and literature reviewFamilial Cancer, 2021
- Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumorsVirchows Archiv, 2021
- Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning networkCancer Causes & Control, 2019
- A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot studyAnalytica Chimica Acta, 2019
- Early‐onset colorectal cancer in young individualsMolecular Oncology, 2018